CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Cash Flows from Operating Activities:
Net income	$ 7,179	$ 8,715
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,009	2,003
Amortization on right-of-use assets	1,922	1,656
Provision (Recovery) for bad debts	2,825	(978)
Deferred income tax - net	1,962	1,816
Compensatory element of stock issuances	83
Stock issued for costs and expense	1,941	1,990
Abandoned patents	1
(Increase) decrease in operating assets, net:
Accounts, medical and management fee receivable(s)	(5,549)	(4,300)
Notes receivable	25	11
Costs and estimated earnings in excess of billings on uncompleted contracts		372
Inventories	(195)	47
Income tax receivable	671
Prepaid expenses and other current assets	452	330
Other assets	(1)	(45)
Increase (decrease) in operating liabilities, net:
Accounts payable	233	(576)
Other current liabilities	(2,748)	430
Operating lease liabilities	(1,657)	(1,447)
Financing lease liabilities	24
Customer deposits	378	28
Billings in excess of costs and estimated earnings on uncompleted contracts		12
Other liabilities	(3)	123
Net cash provided by operating activities	9,552	10,187
Cash Flows from Investing Activities:
Purchases of property and equipment	(2,143)	(4,656)
Purchase of short term investment		(199)
Cost of patents	(90)	(62)
Net cash used in investing activities	(2,233)	(4,917)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(35)	(24)
Proceeds from debt	63
Distributions to noncontrolling interests	(3,570)	(3,735)
Net cash used in financing activities	(3,542)	(3,759)
Net Increase in Cash and Cash Equivalents	3,777	1,511
Cash and Cash Equivalents - Beginning of Period	36,802	13,882
Cash and Cash Equivalents - End of Period	$ 40,579	$ 15,393